267 related articles for article (PubMed ID: 18462180)
1. Antidepressants use in pediatric populations.
Gören JL
Expert Opin Drug Saf; 2008 May; 7(3):223-5. PubMed ID: 18462180
[TBL] [Abstract][Full Text] [Related]
2. Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression.
Valluri S; Zito JM; Safer DJ; Zuckerman IH; Mullins CD; Korelitz JJ
Med Care; 2010 Nov; 48(11):947-54. PubMed ID: 20856141
[TBL] [Abstract][Full Text] [Related]
3. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries.
Rihmer Z; Akiskal H
J Affect Disord; 2006 Aug; 94(1-3):3-13. PubMed ID: 16712945
[TBL] [Abstract][Full Text] [Related]
4. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF
Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
[TBL] [Abstract][Full Text] [Related]
5. Antidepressants and suicidality: the basis of controversies.
Marcinko D
Psychiatr Danub; 2007 Sep; 19(3):238-40. PubMed ID: 17914327
[TBL] [Abstract][Full Text] [Related]
6. Persisting decline in depression treatment after FDA warnings.
Libby AM; Orton HD; Valuck RJ
Arch Gen Psychiatry; 2009 Jun; 66(6):633-9. PubMed ID: 19487628
[TBL] [Abstract][Full Text] [Related]
7. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs.
Valuck RJ; Libby AM; Orton HD; Morrato EH; Allen R; Baldessarini RJ
Am J Psychiatry; 2007 Aug; 164(8):1198-205. PubMed ID: 17671282
[TBL] [Abstract][Full Text] [Related]
8. Adolescent angst or true intent? Suicidal behavior, risk, and neurobiological mechanisms in depressed children and teenagers taking antidepressants.
Morrison J; Schwartz TL
Int J Emerg Ment Health; 2014; 16(1):247-50. PubMed ID: 25345238
[TBL] [Abstract][Full Text] [Related]
9. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs.
Libby AM; Brent DA; Morrato EH; Orton HD; Allen R; Valuck RJ
Am J Psychiatry; 2007 Jun; 164(6):884-91. PubMed ID: 17541047
[TBL] [Abstract][Full Text] [Related]
10. Pediatric prescribing practices and the FDA Black-box warning on antidepressants.
Cheung A; Sacks D; Dewa CS; Pong J; Levitt A
J Dev Behav Pediatr; 2008 Jun; 29(3):213-5. PubMed ID: 18550990
[TBL] [Abstract][Full Text] [Related]
11. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
Hjalmarsson L; Corcos M; Jeammet P
Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
[TBL] [Abstract][Full Text] [Related]
12. A black-box warning for antidepressants in children?
Newman TB
N Engl J Med; 2004 Oct; 351(16):1595-8. PubMed ID: 15483275
[No Abstract] [Full Text] [Related]
13. Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.
Gupta S; Gersing KR; Erkanli A; Burt T
Psychiatr Q; 2016 Jun; 87(2):329-42. PubMed ID: 26303613
[TBL] [Abstract][Full Text] [Related]
14. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
15. Depression, antidepressants and suicidality: a critical appraisal.
Licinio J; Wong ML
Nat Rev Drug Discov; 2005 Feb; 4(2):165-71. PubMed ID: 15688079
[TBL] [Abstract][Full Text] [Related]
16. Changes in antidepressant medications prescribing trends in children and adolescents in Hawai'i following the FDA black box warning.
Hassanin H; Harbi A; Saif A; Davis J; Easa D; Harrigan R
Hawaii Med J; 2010 Jan; 69(1):17-9. PubMed ID: 20222492
[TBL] [Abstract][Full Text] [Related]
17. Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs.
Morrato EH; Libby AM; Orton HD; Degruy FV; Brent DA; Allen R; Valuck RJ
Am J Psychiatry; 2008 Jan; 165(1):42-50. PubMed ID: 17986680
[TBL] [Abstract][Full Text] [Related]
18. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
Akiskal HS; Benazzi F
J Affect Disord; 2006 Aug; 94(1-3):105-10. PubMed ID: 16766043
[TBL] [Abstract][Full Text] [Related]
19. Pediatric antidepressant use after the black-box warning.
Busch SH; Barry CL
Health Aff (Millwood); 2009; 28(3):724-33. PubMed ID: 19414881
[TBL] [Abstract][Full Text] [Related]
20. [The psychopharmacological treatment of depressive disorders in childhood and adolescence - developments and standards since the «black box» warning].
Plener PL; Fegert JM; Kölch MG
Z Kinder Jugendpsychiatr Psychother; 2012 Nov; 40(6):365-71. PubMed ID: 23109125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
